Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jake Class"'
Autor:
Vinothini Arunagiri, Laura Cooper, Huali Dong, Jake Class, Indrani Biswas, Sujan Vahora, Riddhi Deshpande, Khushi H. Gopani, Guochang Hu, Justin M. Richner, Lijun Rong, Jing Liu
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been demonstrated to limit the host interferon response; however, the underlying mechanism remains unclear. Here, we found that SARS-CoV-2 infection upregulated the E3 ubiquitin ligase
Externí odkaz:
https://doaj.org/article/1c877b442ba24ad0a7df4f6d1c8abd34
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology
Supplemental Digital Content is available in the text.
Objective: SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is a major cause of morbidity and mortality, often as a result of acute respiratory distress syndrome. Respi
Objective: SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is a major cause of morbidity and mortality, often as a result of acute respiratory distress syndrome. Respi
Autor:
Jake Class, Lavanya Visvabharathy, Thomas Ciucci, Pablo Penaloza-MacMaster, Nicole Palacio, Igor J. Koralnik, Tanushree Dangi, Mincheol Park, Sarah Sanchez, Justin M. Richner
Publikováno v:
J Clin Invest
Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have shown efficacy against SARS-CoV-2, it is unknown if coronavirus vaccines can also protect against other coronaviruses that may infect humans in the future. Here, we s
The SARS CoV-2 pandemic has killed millions of people. This viral infection can also result in substantial morbidity, including respiratory insufficiency and neurological manifestations, such as loss of smell and psychiatric diseases. Most SARS CoV-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::581743abd1fc1efa1a4d66ddb7e95f82
https://doi.org/10.1101/2021.04.26.440920
https://doi.org/10.1101/2021.04.26.440920